Frost & Sullivan Gut Microbiota White Book
Analysis based on 7 articles · First reported Sep 15, 2026 · Last updated Sep 16, 2026
The report is a research publication rather than a transactional event, so its direct market impact is limited and mainly informational for investors tracking the gut microbiota and live biotherapeutics space. It may modestly raise investor attention to microbiome drug developers and probiotic health product makers in China, the United States, Europe, and Canada, but no immediate price-moving action is involved.
Frost & Sullivan published the White Book on the Current Landscape and Future Trends of the Gut Microbiota Industry, a comprehensive research report on the global gut microbiota sector. The report covers the relationship between gut microbiota and health and disease, the current landscape of gut microbiota drug development, market analysis of health supplements, and future trends. It highlights Live Biotherapeutic Products (LBPs), biologics derived from live organisms intended to prevent, treat, or cure human diseases, which the United States — Food and Drug Administration defines as distinct from conventional probiotics and subject to pharmaceutical development standards. Clinical trials for gut microbiota-based therapeutics are concentrated in China, the United States, Europe, and Canada, with fecal microbiota transplantation (FMT) accounting for roughly 44.2% of active pipelines and single-strain microbial therapeutics about 30%. The report notes that Chinese gut microbiota enterprises are expanding globally, supported by market demand, rising investment, and government policies in China, the United States, and the European Union. China reportedly ranks first globally in microbiota-related patent applications with 33% of the total. The report also outlines the industry value chain from upstream diagnostic platforms and strain resources to midstream therapeutics and health products and downstream clinical institutions and consumers, and expects strong growth momentum as regulatory frameworks improve and business models evolve toward personalized health solutions.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard